Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

The macrophage-derived neutrophil chemotactic factor, MNCF: A lectin with TNF-alpha-like activities on neutrophils

Full text
Author(s):
Toledo, Karina Alves [1] ; Pereira, Fernando Lourenco [1] ; Mambole, Agnes [2] ; Lesavre, Philippe [2] ; Roque-Barreira, Maria Cristina [1] ; Halbwachs-Mecarelli, Lise [2]
Total Authors: 6
Affiliation:
[1] Univ Sao Paulo, FMRP, Dept Biol Celular Mol, BR-14049900 Ribeirao Preto - Brazil
[2] Univ Paris 05, INSERM, U845, F-75015 Paris - France
Total Affiliations: 2
Document type: Journal article
Source: Biochemical and Biophysical Research Communications; v. 376, n. 4, p. 764-769, NOV 28 2008.
Web of Science Citations: 1
Abstract

The macro phage-derived neutrophil chemotactic factor (MNCF) is an alpha-galactoside-binding lectin, known to induce dexamethasone-insensitive neutrophil recruitment. We further characterized MNCF effects on neutrophils and showed that it shares with TNF-alpha the ability to delay apoptosis and to trigger degranulation. MNCF and TNF-alpha effects show similar kinetics and involve Src kinases and MAPKinases dependent pathways. They were, however, clearly distinguished, since the soluble TNF-receptor etanercept prevented TNF but not MNCF effects, while melibiose disaccharide inhibited MNCF but not TNF effects. Absorption of MNCF on detoxi-gel did not alter its properties, precluding an LPS contamination effect. By contrast, galectin-3 required LPS to activate neutrophils. Specific antibodies allowed to further demonstrate that MNCF and galectin-3 are two distinct molecules. Finally, MNCF- and IL-8-induced neutrophil activation differed by their kinetic and sensitivity to pertussis toxin. In conclusion, MNCF is a distinct neutrophil agonist, with pro-inflammatory activities involving its carbohydrate recognition domain. (C) 2008 Elsevier Inc. All rights reserved. (AU)

FAPESP's process: 06/60642-2 - Lectins: biological effects and pharmaceutical applications
Grantee:Maria Cristina Roque Antunes Barreira
Support Opportunities: Research Projects - Thematic Grants